Assessment of The Diagnostic Value of TOX Versus CD3 Immunohistochemical Markers in Detection of Early Mycosis Fungoides Cases

Mycosis Fungoides Diagnosis Using TOX Versus Old Panel Immunohistochemical Markers

Evaluation of the molecular marker TOX protein in diagnosis of early stages of mycosis fungoides

Diagnostic Approach of Mycosis Fungoides and Unusual Benign Mimickers

STUDY OF THE ROLE OF SERUM CD163 AS A PROGNOSTIC TOOL IN MYCOSIS FUNGOIDES THERAPY

Validity of Immunohistochemical Expression of Cell Adhesion Molecule 1 (CADM1) in Differentiating Early-Stage Mycosis Fungoides from Its Benign Mimickers

DIAGNOSTIC AND PREDICTIVE VALUE OF SURVIVIN, P63 ANDCD15 IN NON HODGKIN'S LYMPHOMAS

DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF BONE MARROW BIOPSY IN NON HODGKINS LYMPHOMA

THE DIAGNOSTIC VALUE OF CIRCULATING TUMOR NECROSIS FACTOR ALPHA (TNFa) VERSUS ALPHA FETOPROTEIN (AFP) IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

THE VALUE OF IMMUNE INHIBITORY RECEPTOR IMMUNOGLOBULIN-LIKE TRANSCRIPT 3 EXPRESSION IN THE DIAGNOSIS OF ACUTE MYELOID LEUKEMIA WITH MONOCYTIC DIFFERENTIATION